• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Work with us

Code of Conduct

Home > Work with us

Code of Conduct

  • Working at DNDi
  • Diversity, equity & inclusion
  • Code of Conduct
  • Integrity Line

Our Code of Conduct aims to strengthen the ethical culture at DNDi to support decision-making based on our values, and to maintain the respect and confidence of our colleagues, partners, and the donors who support us.

Read our code of conduct
Français

Our values both reflect who we are and guide who we aspire to be. For us to continue our success in developing treatments for neglected patients, strengthening capacities, and inspiring policy change by demonstrating an alternative model, we must strive to work with our staff, external partners, and patients according to our values in everything we do.

Our values

Icon of people together

People-centred

  • We value our colleagues and recognize their contributions
  • We care about the well-being of neglected patients and the communities we work with
  • We nurture a respectful, diverse and inclusive working environment
Icon of person holding a balance

Integrity

  • We are trustworthy and ethical
  • We are fair, transparent, and honest
  • We work to the highest quality to deliver the best science
Icon of light bulb with microscope inside it

Innovation

  • We encourage new ideas
  • We find solutions through collaboration and creative thinking
  • We seek sustainable transformation
Icon of a person holding a flag

Courage

  • We take smart risks
  • We pursue our goals in the face of adversity
  • We are ready to challenge the status quo
Who we are
How we work

Applying the Code of Conduct

We expect everyone working for or with us to observe the standards set forth in our Code of Conduct. This includes our leadership, staff, directors, consultants, volunteers, interns, suppliers, and collaborating partners.

Safeguarding people

We believe that equal opportunity and workforce diversity are vital to the realization of our values. An inclusive work environment that openly values diversity and supports the full contribution of everyone we interact with leads to increased tolerance, respect, productivity, and success.

We are committed to creating a respectful, positive, and harmonious workplace for all our employees. We strive to ensure that all employees are treated with dignity and respect, and that no employee is subjected to harassment.

Our Commitment to Diversity, Equity & Inclusion

Being a trusted partner

Our policies govern our commitment to respecting research and clinical standards; compliance; anti-bribery and anti-corruption; proper documentation and accurate reporting; data privacy and security; avoiding conflicts of interest; and confidentiality.

Our policies

Raising concerns

We expect everyone we work with to prevent and report any kind of actual or potential ethical or legal concern, or to otherwise question or challenge any possible breach of the Code of Conduct, especially where it may adversely impact patients or anyone who is vulnerable.

DNDi’s Integrity Line is an online third-party platform that can be used for the anonymous reporting of misconduct by DNDi staff or anyone outside the organization in connection with DNDi activities. There are also several other reporting channels detailed in our Code of Conduct.

We strictly prohibit retaliation or adverse action against anyone who, in good faith, raises a concern about compliance issues or cooperates with our investigation into an alleged breach of this Code. We will address all allegations of breaches of this Code in a timely, fair, proportional, and confidential manner.

DNDi Code of Conduct

english
Français

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License